Navigation Links
Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
Date:1/27/2011

in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, our ability to successfully integrate Inovio and VGX Pharmaceuticals, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2009, our Form 10-Q for the nine months ended September 30, 2010, and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured,
'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... architecture firm NBBJ announced today the expansion of its healthcare planning and ... will lead planning and design teams from NBBJ,s Shanghai ... clients in China , Taiwan , ... the firm,s global network of healthcare experts.   The launch ... time when the scope of the firm,s healthcare practice in ...
(Date:8/26/2014)... , August 26, 2014 Equashield ... Transfer Devices (CSTDs) for hazardous drugs, announced today it ... top nurses from around the United States ... strategies to increase nurses, awareness of issues around occupational ... safety, and closed systems for hazardous drug transfer. ...
(Date:8/26/2014)... , Aug. 26, 2014  Royal Philips (NYSE: PHG, ... company,s latest innovation designed to empower seniors to live ... the company,s leading U.S.-based call center, the mobile app ... recent survey by Philips and the Global ... School of Business, 96 percent of senior respondents ...
Breaking Medicine Technology:Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 2Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 3Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 4Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China 5Equashield Appoints Nurse Advisory Council 2Equashield Appoints Nurse Advisory Council 3Equashield Appoints Nurse Advisory Council 4Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 3
... 18, 2011 Halozyme Therapeutics, Inc. (NASDAQ: ... commercializing products targeting the extracellular matrix ... markets, today announced that the Phase 3 HannaH ... HER2-positive early breast cancer who received a new, ...
... /PRNewswire-iReach/ -- Dr. Anthony A. Scaduto has been named ... an interim basis effective October 14, 2011. His appointment was ... of Directors. "It is a testament to Dr. ... he was recommended by the Search Committee. He is a ...
Cached Medicine Technology:Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 2Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 3Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 4Los Angeles Orthopaedic Hospital Announces New President and CEO 2Los Angeles Orthopaedic Hospital Announces New President and CEO 3
(Date:8/27/2014)... August 27, 2014 Top10BestSEOHosting.com compares ... and GoDaddy are the most recommended suppliers for ... products. , “GreenGeeks and GoDaddy provide stellar ... believe that they have managed to provide a ... an intuitive ease of use that helps diminish ...
(Date:8/27/2014)... 27, 2014 The world of dating ... was revealed in a survey conducted recently by 10yeargap. ... surprising but astonishing as well, and for older men, ... existing members on the 10yeargap website and even on ... 10yeargap marketing department manager," there are more and more ...
(Date:8/27/2014)... Discover Leadership Training is the foremost ... through their comprehensive leadership programs. As the Vice President ... in the realm of outcome-focused and benefit-driven choices. Barb ... new webinar series titled, “A Women’s Guide to Making ... this two part webinar is titled, “My Current Story” ...
(Date:8/27/2014)... New York, NY (PRWEB) August 27, 2014 ... arrogant failure, he finally found his niche. The Women’s Radio ... KC Armstrong for his continued support and dedication to the ... to be able to have such a positive atmosphere.” After ... producers on Sirius XM of the Howard Stern show, “Howard ...
(Date:8/27/2014)... 27, 2014 Casey Diekman, assistant professor ... (NJIT), is helping to gain greater insight into the ... , Evolution has harmonized the behavior of humans and ... include the cycle of light and dark experienced each ... controls hormone production related to natural patterns of sleep/wake ...
Breaking Medicine News(10 mins):Health News:Excellent Hosting Suppliers Recommended By Top10BestSEOHosting.com 2Health News:Survey Reveals Younger Women Dating Older Men 2Health News:Survey Reveals Younger Women Dating Older Men 3Health News:Barb Moses, Vice President of Discover Leadership Training, Announces New Webinar Titled, “A Women’s Guide to Making Her Life Story a Bestseller” 2Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 3Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 4
... study by Florida State University researchers said, ‘Self-critical adult who ... are grown up in a verbally// abused environment in their ... more likely to have symptoms of depression and anxiety as ... 5,614 people aged between 15 and 54, conducted by Florida ...
... in drug usage in northeastern states, says a United Nations ... in the Northeastern States of India" says that the 70s ... in the early 80s. These years there has been a ... users of these drugs, while female users constitute just 5-10 ...
... refugees staying in camps in North Tripura district have been ... sources today here said. // ,This was found ... by the state health department., ,The department collected blood ... by AIDS and 12 as HIV positive, the sources said., ...
... human-to-human transmission of the deadly bird flu virus among members ... agency has sought to assure the public that potentially dangerous ... however maintained that human contagion cannot be ruled out in ... ,So far there has been no evidence that efficient human-to-human ...
... hospitals are getting dirtier despite promises, claimed patients in a ... ,The annual NHS patients survey has found high ... more specific questions were asked of the 80,000 people who ... that their ward ha been ‘very clean’ as compared to ...
... who were on a hunger strike over quota issue at ... , called off the strike tonight, according to action committee ... over 700-odd medicos in the region has entered its tenth ... the aegis of Indian Medical Association (Gujarat unit) office from ...
Cached Medicine News:Health News:Quality Of NHS Hospitals Getting Dirtier Despite Promises 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: